JP Morgan Chase’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
JP Morgan Chase's ACLS Position: Q2 2026 in Review
JP Morgan Chase reduced its Axcelis (ACLS) stake by 80% in Q2 2026, selling an estimated $26.5M and leaving 44,011 shares worth $8M. The position accounts for ﹤0.01% of the portfolio, ranked #3019.
JP Morgan Chase first reported a position in ACLS in Q2 2013 and has held it in 46 quarters since. The position peaked at $73.2M in Q4 2023. 440 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- JP Morgan Chase held 44,011 shares of Axcelis worth $8M as of Q2 2026.
- JP Morgan Chase sold 178,703 Axcelis shares in Q2 2026, an estimated $26.5M.
- Axcelis made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3019 holding.
- JP Morgan Chase first reported a position in Axcelis in Q2 2013 and has held it in 46 quarters since.
- JP Morgan Chase's Axcelis position peaked at $73.2M in Q4 2023.
- 440 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.